The senior living operator runs brain health programming for hundreds of residents and still can’t say, with confidence, which ones are genuinely improving. The rehabilitation provider clears a patient to return to activity based on symptoms, not on whether the underlying deficit is actually resolved. The sports organization has to decide, in real time, whether an athlete is truly ready to perform under pressure, often with little more than instinct and a stopwatch. The pharmaceutical company can point to trial results, but not to how a patient is actually doing at home, three months later, under real-world conditions.
Different markets, different interventions, the same uncomfortable admission: none of them have a reliable way to measure whether what they’re doing is actually working.
This is the blind spot the brain health sector would rather not talk about.
Investment is flooding into interventions at an accelerating pace. Governments, health systems, research institutions, and venture capital are all funding the next generation of drugs, therapies, wearables, and cognitive training platforms. But the measurement infrastructure required to prove any of it works hasn’t kept up. Organizations are spending significant money and still operating largely on intuition when it comes to outcomes. That’s the quiet signal that brain health is entering its infrastructure era, whether the field has caught up to it or not.
The Structural Problem With How We Measure Brain Performance
The standard approach to measuring brain health separates the brain and the body. Cognitive measurements capture memory, attention, processing speed, and executive function. Motor measurements capture balance, reaction time, gait, and coordination. Both have real clinical value. Both also miss the thing that actually determines whether someone can function in the real world.
Human performance doesn’t split neatly into cognitive and motor columns. Independence, recovery, and readiness all depend on neuromotor control: the brain’s ability to process information and execute movement simultaneously under changing conditions. It’s the system that governs whether someone can navigate an unpredictable environment without falling, whether an athlete can execute under pressure, whether a worker can hold performance in a cognitively demanding, physically active role.
When measurements evaluate the brain and body separately, they miss what’s happening at the intersection, and that’s exactly where the risk lives. Individuals can appear cognitively intact while meaningful change in neuromotor function is already underway. Athletes can pass return-to-play protocols while persistent deficits remain. Patients can look stable on paper while the functional changes driving their real risk stay invisible to the tools being used to evaluate them.
The signal is almost always there before the symptoms are. Neuromotor control is where it shows up first, and it’s the one thing almost nothing on the market is built to measure.
The brain health intervention landscape is expanding in every direction at once, and the number of organizations making meaningful claims about brain health outcomes is growing faster than the field’s shared ability to validate those claims. New pharmaceutical candidates for cognitive decline, digital therapeutics, wearables, AI-powered measurement tools, longevity protocols with brain health as a core pillar, workplace performance programs, concussion management systems: all of it is moving fast, and all of it would benefit from a common way to prove it’s working.
That mismatch has real consequences. Without longitudinal measurement of brain performance, providers and program operators run into the same wall from different directions:
Intervention decisions get made without a baseline. If you never established what a patient’s or resident’s neuromotor function looked like before an intervention, you have nothing to measure change against.
Return-to-activity decisions rest on incomplete data. Protocols built on symptom resolution or isolated cognitive and motor scores can clear people who still have meaningful functional deficits.
Program outcomes are difficult to prove. Operators investing in brain health programming need to demonstrate results to residents, patients, payers, and boards. Without a consistent measurement framework, that case is hard to make convincingly.
Research runs into the same ceiling. Studies measuring the impact of drugs, therapies, or training programs on cognition have rarely had access to a reliable measure of neuromotor function as an outcome variable, which limits both the questions researchers can ask and the conclusions they’re able to draw.
A different approach is emerging: measuring the brain and body together, because that’s where the meaningful information actually lives. Testing memory or balance in isolation only tells part of the story. The full picture only shows up when the brain is measured under load, coordinating with the body in real time. That’s neuromotor control: the brain’s ability to process information and execute movement simultaneously under changing conditions. It’s the layer that reveals how the brain and body actually function together, and it’s the layer most measurement tools still miss.
Instead of two isolated scores, integrated neuromotor measurement produces a single Brain Performance Score™, a profile of how a person’s brain controls movement under cognitive load, established as a baseline and tracked over time.
The applications cut across nearly every setting brain health touches. For senior living and active aging operators, it’s a way to prove whether programming is translating into functional improvement, not just participation. For rehabilitation providers, it’s an objective input for return-to-activity decisions that goes beyond a symptom checklist. For sports performance and occupational health, it’s a readiness benchmark grounded in neuromotor function instead of assumption.
None of this is speculative. The sensorimotor neuroscience connecting Neuromotor Control to functional outcomes spans more than two decades and over 50 peer-reviewed studies. What’s been missing isn’t the science. It’s a way to bring that science into everyday clinical and operational settings that’s simple enough to use without specialized training, intuitive enough that results make sense on sight, and standardized enough that a score means the same thing in a senior living facility as it does on a sideline.
Every era of healthcare innovation eventually gets sorted the same way: not by who has the most interventions, but by who can prove those interventions work. Vital signs became foundational to medicine for exactly that reason. Blood pressure. Heart rate. Oxygen saturation. None of them replaced clinical judgment. They gave it something to stand on.
Brain health hasn’t had its version of that yet. The organizations that build measurement capability now, ahead of the mandate rather than in response to it, will be the ones setting the standard everyone else eventually gets held to. The ones that wait will be measured against a bar they didn’t get to help define.
That shift is already underway, quietly, in a handful of settings most of the industry hasn’t noticed yet. And that’s genuinely exciting. Brain health is entering its infrastructure era: the point where a field stops asking whether something works and starts being able to prove it, for every patient, every program, every intervention that deserves the chance to show its value. The organizations willing to build toward that now won’t just be ahead of a curve; they’ll be the ones who finally give this entire field the language it’s been missing to describe its own progress.
About Reed Hanoun
Reed Hanoun is a four-time founder and multi-exit entrepreneur with 25+ years of turning breakthrough ideas into scalable platforms that change how the world measures human performance. His founder journey spans Hanoun Medical, MyTrak Health, and 3motionAI — three companies that each pushed the frontier of human performance measurement. At NERON AI, he is building what they all pointed toward: a global standard for making Neuromotor Control measurable, trainable, and trackable across the full arc of human life.
